FHACT® takes the guess work out of cervical cancer screening

WATCH THE VIDEO >

Get answers,
get FHACT®.
Webinar series.

LEARN MORE >

FHACT® is indicated for HPV-positive ASCUS and LSIL patients.

LEARN MORE >

FHACT® is the only FISH Probe to assess four biomarkers associated with cervical cancer.

Learn More

Latest News

29 May 15

Cancer Genetics to Report Findings of Kidney Cancer Treatment Study From Research Collaboration at the 2015 ASCO Annual Meeting (read more...)

- RUTHERFORD, N.J., May 29, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "The Company"), an emerging leader in DNA-based (read more...)
26 May 15

Cancer Genetics Selected to Power Next-Generation Sequencing Services for ReproCELL, a Global Regenerative Medicine Market Leader, in a Multi-Year Agreement (read more...)

- RUTHERFORD, N.J. and HYDERABAD, India, May 26, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company") announced today(read more...)

Events

14 May 15

Annual Meeting of Stockholders

- The meeting will be held at the offices of the Company, located at 201 Route 17 North, 2nd Floor, Rutherford, New Jersey 07070. Proxy Statement(read more...)
12 May 15

1st Quarter 2015 Conference Call

05 May 15

International Society for Biological and Environmental Repositories

Clinicians
Patients